INS and Alzheimer disease: There were no notable differences in mTOR and Rictor expression levels and mTOR—Rictor association between AD and healthy controls and no effects of insulin or simufilam on this interaction, despite a slight increase in insulin-stimulated mTORC2 levels in AD on Day 0 (Figure 2D).